NEW YORK (GenomeWeb News) — Sloning Biotechnology of Puchheim, Germany, on Monday said that Research and Innovation Japan will exclusively market and distribute its Slonomics gene-synthesis service and its Slonomax gene-mutant libraries in Japan.
 
“Sloning's products and services perfectly address the current demand in genomics research and protein engineering,” RIJ CEO Kiyohiko Hirasawa said in a statement.
 
Financial terms of the agreement were not released.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The apple has traveled westward and eastward along the Silk Road, according to a new genetic analysis.

In Nature this week: GWAS data used to reposition drugs for psychiatric use, and more.

Genetic disease risk information doesn't always spur people to make healthy lifestyle changes, according to the Associated Press.

A University of California, San Diego-led team has used liquid biopsies to uncover possible treatments for patients with cancers of unknown primary.